The World’s Original Fat Reduction Technology “Cryolipolysis”1
an Advanced Fat Freezing Technology that freezes body fat cells away

Over 17 million

treatment done worldwide2

Impressive scientific evidence

CoolSculpting® is the only cryolipolysis device with over 120 peer-reviewed publications*5

Non-invasive,

Lasting results,
Minimal downtime11, 12

The new CoolSculpting® Elite makes every Details count for your
Non-invasive Fat Reduction Treatment

EVERY Hour  COUNTS

POWERED FOR
DUALITY

New CoolSculpting® Elite gives you beyond the results, but also efficiency.

1 machine x
2 applicators

As fast as 35mins
in one treatment session9.

Receive twice the result in single treatment session9.

EVERY Outcome  COUNTS

Fat reduction

up to -27%(6)

US FDA-cleared13 for
NON-INVASIVE BODY CONTOURING

EVERY Contour  COUNTS

C THE
DIFFERENCE

Better Fit for Better Results

Our new C-shaped cups are engineered to complement the body’s natural curves and to improve fit during tissue draw and features up to an 18% larger cooling area as compared to the previous generation.7,8

SAFETY FIRST

CoolSculpting® Elite is US FDA-approved13 and it has precise technologies in place to ensure optimal results under a safe procedure.

Freeze Detect®

Patented sensors are
designed to monitor tissue,
stopping treatment if a
potential freeze condition
is detected.9

Coolcontrol

Sensors track treatment
temperature in real time
and adjust the cooling
power to optimise
patient outcome.6

Gel Pad

As an additional measure, our thermal coupling gel pad provides consistent thermal contact between applicator and skin, to help protect your skin.9

HOW CoolSculpting® ELITE  WORKS

Target

We start by targeting and cooling fat cells to a temperature that will trigger apoptosis, or a natural cell death.4

Freeze

Since fat is more sensitive to cold than the surrounding tissue, lipids in fat crystallize at a warmer temperature than water in other cell types.4

Reduce

Following treatment, body’s immune system will naturally eliminate dead cells which can result in up to 27% reduction of stubborn fat.6

Back to the Top

Ready to discover if CoolSculpting® Elite is right for you?

Find a Clinic

India Use:

  • CoolSculpting® and CoolSculpting® Elite is intended for fat layer reduction through cold assisted lipolysis.

Abridged safety information:

The suitability of treatment on an individual patient basis should always be considered as part of the assessment and consultation process. CoolSculpting® and CoolSculpting® Elite are not suitable for all patients. Patient results may vary. Lipolysis is not a reliable method for weight reduction. Devices have not been validated for the treatment of clinically diagnosed obesity and therefore should not be used for such purposes. You should always consult a healthcare

professional to help you decide if CoolSculpting®/ CoolSculpting® Elite is right for you and provide you with a full list of side effects. To learn more about CoolSculpting®/CoolSculpting® Elite please visit www.coolsculptingin.com for further information. Images are for illustrative purposes only. This content is intended for India adult (>18yrs) audience only. Tell your doctor if you have any medical conditions including recent surgery, pre-existing hernia and any known sensitivities or allergies. Tell your doctor if you are pregnant or have any medical conditions including recent surgery, pre-existing hernia, and any known sensitivities or allergies. During or after the procedure you may experience pulling, tugging, mild pinching, intense cold, tingling, stinging, skin inflammation, aching, redness, swelling, blanching, mild to moderate bruising, firmness, tenderness, cramping and discomfort, itching, skin sensitivity, and sensory alteration that can persist for up to several weeks after treatment. After submental treatment, you may feel throat discomfort/soreness and feel fullness in the back of the throat. Rare side effects include paradoxical hyperplasia, late-onset pain, severe pain, hyperpigmentation/hypopigmentation, freeze burn, headache/occipital pain, treatment area demarcation, vasovagal symptoms, subcutaneous induration, cold panniculitis and hernia may also occur. The procedure should only be undertaken with physician advice and is not for those who are under 18 years old, suffer from cryoglobulinemia, cold agglutinin disease or paroxysmal cold haemoglobinuria, pyrexia, uncontrolled hypertension, diabetes mellitus, phlebitis, vasculitis, cancer, tumours, vascular fragility, circulatory system disease (such as lung or heart)or have an incapability to understand the consequences, implications, and risks of the use of the device in conjunction with necessary medical procedures. Lipolysis is not a reliable method for weight reduction. Consideration should be given to exercise and dietary as well as lifestyle modification, both as an alternative to liposuction and lipolysis and to maintain any reduction in adipose tissue which these procedures may achieve. Devices have not been validated for the treatment of clinically diagnosed obesity and therefore should not be used for such purposes. Please see the user manuals for the full list of side effects Medical/CoolSculpting® devices have associated risks, please refer to the contraindications, warnings and precautions sections in the User Manuals/Instructions for Use https://devices.abbvie.com. CoolSculpting®, the CoolSculpting® logo, and the Snowflake design are registered trademarks of Allergan Aesthetics, an AbbVie company. ZELTIQ® is part of Allergan Aesthetics, an AbbVie company. Adverse events should be reported to Allergan Aesthetics, an AbbVie company © 2025 AbbVie AGN-coolsculpting.apacsupport@abbvie.com. All rights reserved. Promotional materials provided by Allergan Aesthetics, an AbbVie company. Website https://www.coolsculptingin.com/

References:

* As of February 2022. Additional publications may exist that are not captured by a PubMed search, for example conference abstracts or journals not indexed by PubMed. Off-label use of cryolipolysis devices was excluded. Includes English language publications only.

  1. Food and Drug Administration. K080521. ZELTIO® Dermal cooling device. September 2010. REF-73095
  2. Allergan. Data on File. CoolSculpting® Number of CoolSculpting® treatment cycles to date. June 2023
  3. Manstein D et al. Lasers Surg Med 2008; 40: 595-604
  4. Zelickson B, et al. Derm Surg 2009; 35:1462-70
  5. Allergan Aesthetics. Data on file. CoolSculpting® and competitor publications. August 2024. REF-105612
  6. Sasaki GH, et al. Aesthet Surg J 2014; 34:420-31
  7. Allergan. Unpublished data. INT-CSC-2050028. CoolSculpting® clinical “Fit and Function” study to test the V003 wells. February 2020.
  8. Allergan. Unpublished data. INT-CSC-2050288. Applicator cooling and distribution dye test. August 2020.EN-A.
  9. CoolSculpting® System (CoolSculpting® Elite) user manual. CS-UM-CM3-07-EN-E. Feb 2023.
  10. Manstein D et al. Lasers Surg Med 2008; 40: 595-604
  11. Avram MM and Harry RS. Lasers Surg Med 2009; 41:703-8
  12. Krueger N, et al. Clin Cosmet Investig Derm 2014; 7:201-25
  13. FDA 501(K) Summary Document, Available at : http://www.accessdata.fda.gov/ [Accessed February 2022].

Disclaimer: CoolSculpting is not a weight loss treatment.

IN-CSC-260020 Date of Preparation: March 2026